Nektar Therapeutics | NKTR - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 19.52B 1.37B 2026-03
Baxter International USD 1.09B 87M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cara Therapeutics USD 3.22M 859K 2025-12
Cipla INR 32.3B 1.95B 2026-03
Dr.Reddys Laboratories INR 30.38B 10.42B 2026-03
Eisai JPY 75.89B 9.6B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.29M 500K 2026-03
Merck USD 3.86B 541M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Roche Holding CHF 5.54B 237M 2026-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Takeda JPY 491.34B 23.75B 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Xencor USD 7.92M 2.91M 2026-03